CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Sunitinib

舒尼替尼 杂质对照品Sunitinib Impurities

62 个杂质条目62 impurity entries

本页汇总 舒尼替尼 的 62 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 62 impurity reference standards of Sunitinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 舒尼替尼(Sunitinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesPhysicochemical characteristics of sunitinib malate and its process-related impurities
    Journal of pharmaceutical sciences · 2013 · Sidoryk K et al.  ·  PMID 23233239  ·  DOI
  2. 杂质研究Impurity studiesDR5/WDR12 balances p65 stability promoting sunitinib resistance in renal cell carcinoma
    Cell death and differentiation · 2026 · Tao W et al.  ·  PMID 41872532  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and Validation of an LC-MS/MS Method for Simultaneous Quantification of Pazopanib, Cabozantinib, Sorafenib, Axitinib, Tivozanib, Sunitinib, and the Metabolites Sorafenib N-Oxide and Desethyl-Sunitinib in Human Plasma
    Pharmaceuticals (Basel, Switzerland) · 2026 · Greibe E et al.  ·  PMID 42653677  ·  DOI
  4. 分析方法Analytical MethodsSpectrophotometric Methods for Determination of Sunitinib in Pharmaceutical Dosage Forms Based on Ion-pair Complex Formation
    Iranian journal of pharmaceutical research : IJPR · 2020 · Souri E et al.  ·  PMID 33680014  ·  DOI
  5. 分析方法Analytical MethodsAn HPLC method for simultaneous quantification of sunitinib and its active metabolite, SU12662, using hydrophilic interaction chromatography principle
    Bioanalysis · 2020 · Gurjar M et al.  ·  PMID 31928228  ·  DOI

舒尼替尼 —— 原料药与杂质对照品Sunitinib — drug substance & impurities

共 63 个条目(含原料药本体)63 items incl. the drug substance
Sunitinib structure
原料药 APIAPI
舒尼替尼Sunitinib
Sunitinib
CAS No.557795-19-4
Chemical FormulaC22H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Malate structure
—
苹果酸舒尼替尼Sunitinib Malate
Sunitinib Malate
CAS No.341031-54-7
Chemical FormulaC22H27FN4O2·C4H6O5
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 1 structure
1
舒尼替尼杂质1Sunitinib Impurity 1
Sunitinib Impurity 1
CAS No.452105-33-8
Chemical FormulaC16H13FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 2 structure
2
舒尼替尼杂质2Sunitinib Impurity 2
Sunitinib Impurity 2
CAS No.356068-97-8
Chemical FormulaC20H23FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 3 structure
3
舒尼替尼杂质3Sunitinib Impurity 3
Sunitinib Impurity 3
CAS No.356068-86-5
Chemical FormulaC14H23N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 4 structure
4
舒尼替尼杂质4Sunitinib Impurity 4
Sunitinib Impurity 4
CAS No.1186651-51-3
Chemical FormulaC16H14FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 5 structure
5
舒尼替尼杂质5Sunitinib Impurity 5
Sunitinib Impurity 5
CAS No.2411816-51-6
Chemical FormulaC18H18FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 6 structure
6
舒尼替尼杂质6Sunitinib Impurity 6
Sunitinib Impurity 6
CAS No.356068-99-0
Chemical FormulaC22H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 7 structure
7
舒尼替尼杂质7Sunitinib Impurity 7
Sunitinib Impurity 7
CAS No.1217294-71-7
Chemical FormulaC18H19FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 8 structure
8
舒尼替尼杂质8Sunitinib Impurity 8
Sunitinib Impurity 8
CAS No.2135339-43-2
Chemical FormulaC20H20FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 9 structure
9
舒尼替尼杂质9Sunitinib Impurity 9
Sunitinib Impurity 9
CAS No.326914-17-4
Chemical FormulaC20H23FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 10 structure
10
舒尼替尼杂质10Sunitinib Impurity 10
Sunitinib Impurity 10
CAS No.2411816-47-0
Chemical FormulaC22H25FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 12 structure
12
舒尼替尼杂质12Sunitinib Impurity 12
Sunitinib Impurity 12
CAS No.1691223-83-2
Chemical FormulaC22H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 22 structure
22
舒尼替尼杂质22Sunitinib Impurity 22
Sunitinib Impurity 22
CAS No.2199-62-4
Chemical FormulaC7H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 23 structure
23
舒尼替尼杂质23Sunitinib Impurity 23
Sunitinib Impurity 23
CAS No.2199-61-3
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 25 structure
25
舒尼替尼杂质25Sunitinib Impurity 25
Sunitinib Impurity 25
CAS No.356068-98-9
Chemical FormulaC12H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 26 structure
26
舒尼替尼杂质26Sunitinib Impurity 26
Sunitinib Impurity 26
CAS No.56341-41-4
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 27 structure
27
舒尼替尼杂质27Sunitinib Impurity 27
Sunitinib Impurity 27
CAS No.253870-02-9
Chemical FormulaC8H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 28 structure
28
舒尼替尼杂质28Sunitinib Impurity 28
Sunitinib Impurity 28
CAS No.2199-51-1
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 29 structure
29
舒尼替尼杂质29Sunitinib Impurity 29
Sunitinib Impurity 29
CAS No.2199-59-9
Chemical FormulaC10H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 32 structure
32
舒尼替尼杂质32Sunitinib Impurity 32
Sunitinib Impurity 32
CAS No.443-69-6
Chemical FormulaC8H4FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 33 structure
33
舒尼替尼杂质33Sunitinib Impurity 33
Sunitinib Impurity 33
CAS No.283584-52-1
Chemical FormulaC8H6FN3O
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 34 structure
34
舒尼替尼杂质34Sunitinib Impurity 34
Sunitinib Impurity 34
CAS No.2436-79-5
Chemical FormulaC12H17NO4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 35 structure
35
舒尼替尼杂质35Sunitinib Impurity 35
Sunitinib Impurity 35
CAS No.5442-91-1
Chemical FormulaC10H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 40 structure
40
舒尼替尼杂质40Sunitinib Impurity 40
Sunitinib Impurity 40
CAS No.1467015-10-6
Chemical FormulaC18H18FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 42 structure
42
舒尼替尼杂质42Sunitinib Impurity 42
Sunitinib Impurity 42
CAS No.1348032-93-8
Chemical FormulaC18H18FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 44 structure
44
舒尼替尼杂质44Sunitinib Impurity 44
Sunitinib Impurity 44
CAS No.1104253-05-5
Chemical FormulaC18H17FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 50 structure
50
舒尼替尼杂质50Sunitinib Impurity 50
Sunitinib Impurity 50
CAS No.251356-82-6
Chemical FormulaC12H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 55 structure
55
舒尼替尼杂质55Sunitinib Impurity 55
Sunitinib Impurity 55
CAS No.1309935-08-7
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 56 structure
56
舒尼替尼杂质56Sunitinib Impurity 56
Sunitinib Impurity 56
CAS No.590424-05-8
Chemical FormulaC13H23N3O
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 57 structure
57
舒尼替尼杂质57Sunitinib Impurity 57
Sunitinib Impurity 57
CAS No.2365-44-8
Chemical FormulaC8H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 58 structure
58
舒尼替尼杂质58Sunitinib Impurity 58
Sunitinib Impurity 58
CAS No.856436-17-4
Chemical FormulaC15H13FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 60 structure
60
舒尼替尼杂质60Sunitinib Impurity 60
Sunitinib Impurity 60
CAS No.17120-26-2
Chemical FormulaC8H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 61 structure
61
舒尼替尼杂质61Sunitinib Impurity 61
Sunitinib Impurity 61
CAS No.100487-78-3
Chemical FormulaC8H6ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 67 structure
67
舒尼替尼杂质67Sunitinib Impurity 67
Sunitinib Impurity 67
CAS No.2385122-27-8
Chemical FormulaC8H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 68 structure
68
舒尼替尼杂质68Sunitinib Impurity 68
Sunitinib Impurity 68
CAS No.2377533-90-7
Chemical FormulaC22H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 69 structure
69
舒尼替尼杂质69Sunitinib Impurity 69
Sunitinib Impurity 69
CAS No.873077-70-4
Chemical FormulaC18H19FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 70 structure
70
舒尼替尼杂质70Sunitinib Impurity 70
Sunitinib Impurity 70
CAS No.2170562-55-5
Chemical FormulaC18H18FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 71 structure
71
舒尼替尼杂质71Sunitinib Impurity 71
Sunitinib Impurity 71
CAS No.356068-93-4
Chemical FormulaC16H13FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 72 structure
72
舒尼替尼杂质72Sunitinib Impurity 72
Sunitinib Impurity 72
CAS No.1246833-23-7
Chemical FormulaC25H31FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 73 structure
73
舒尼替尼杂质73Sunitinib Impurity 73
Sunitinib Impurity 73
CAS No.2542023-49-2
Chemical FormulaC25H31FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 74 structure
74
舒尼替尼杂质74Sunitinib Impurity 74
Sunitinib Impurity 74
CAS No.1227960-76-0
Chemical FormulaC23H27FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 75 structure
75
舒尼替尼杂质75Sunitinib Impurity 75
Sunitinib Impurity 75
CAS No.2417674-05-4
Chemical FormulaC23H27FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 76 structure
76
舒尼替尼杂质76Sunitinib Impurity 76
Sunitinib Impurity 76
CAS No.83615-76-3
Chemical FormulaC13H10N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 79 structure
79
舒尼替尼杂质79Sunitinib Impurity 79
Sunitinib Impurity 79
CAS No.14352-65-9
Chemical FormulaC8H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 81 structure
81
舒尼替尼杂质81Sunitinib Impurity 81
Sunitinib Impurity 81
CAS No.2199-58-8
Chemical FormulaC7H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 90 structure
90
舒尼替尼杂质90Sunitinib Impurity 90
Sunitinib Impurity 90
CAS No.56341-39-0
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 91 structure
91
舒尼替尼杂质91Sunitinib Impurity 91
Sunitinib Impurity 91
CAS No.17630-75-0
Chemical FormulaC8H6ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 92 structure
92
舒尼替尼杂质92Sunitinib Impurity 92
Sunitinib Impurity 92
CAS No.1782113-87-4
Chemical FormulaC16H8F2N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 93 structure
93
舒尼替尼杂质93Sunitinib Impurity 93
Sunitinib Impurity 93
CAS No.351-09-7
Chemical FormulaC8H7FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 94 structure
94
舒尼替尼杂质94Sunitinib Impurity 94
Sunitinib Impurity 94
CAS No.319-64-2
Chemical FormulaC8H5FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 95 structure
95
舒尼替尼杂质95Sunitinib Impurity 95
Sunitinib Impurity 95
CAS No.342641-94-5
Chemical FormulaC22H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 96 structure
96
舒尼替尼杂质96Sunitinib Impurity 96
Sunitinib Impurity 96
CAS No.138343-94-9
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 97 structure
97
舒尼替尼杂质97Sunitinib Impurity 97
Sunitinib Impurity 97
CAS No.71294-03-6
Chemical FormulaC8H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 98 structure
98
舒尼替尼杂质98Sunitinib Impurity 98
Sunitinib Impurity 98
CAS No.2417674-06-5
Chemical FormulaC21H25FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 106 structure
106
舒尼替尼杂质106Sunitinib Impurity 106
Sunitinib Impurity 106
CAS No.2377533-92-9
Chemical FormulaC22H25FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 107 (Mixture of E/Z-isomers) structure
107
舒尼替尼杂质107 (混合E/Z构型)Sunitinib Impurity 107 (Mixture of E/Z-isomers)
Sunitinib Impurity 107 (Mixture of E/Z-isomers)
CAS No.356069-16-4
Chemical FormulaC20H23FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 108 structure
108
舒尼替尼杂质108Sunitinib Impurity 108
Sunitinib Impurity 108
CAS No.324-03-8
Chemical FormulaC8H4FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 109 structure
109
舒尼替尼杂质109Sunitinib Impurity 109
Sunitinib Impurity 109
CAS No.10197-51-0
Chemical FormulaC14H10F2N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 111 structure
111
舒尼替尼杂质111Sunitinib Impurity 111
Sunitinib Impurity 111
CAS No.5434-29-7
Chemical FormulaC8H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 115 structure
115
舒尼替尼杂质115Sunitinib Impurity 115
Sunitinib Impurity 115
CAS No.879274-72-3
Chemical FormulaC8H7FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 116 structure
116
舒尼替尼杂质116Sunitinib Impurity 116
Sunitinib Impurity 116
CAS No.326914-09-4
Chemical FormulaC22H28N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Sunitinib Impurity 72-d5 structure
72-D5
舒尼替尼杂质72-d5Sunitinib Impurity 72-d5
Sunitinib Impurity 72-d5
CAS No.1246832-84-7
Chemical FormulaC25H26D5FN4O4
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

舒尼替尼 —— 研究文献与合成路线Sunitinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 舒尼替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Sunitinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib
    Xu Z, Jin Y, Gao Z, et al. · Autophagy · 2022 · 被引 52cited 52
  2. HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport
    Luo P, Xu Z, Li G, et al. · Autophagy · 2018 · 被引 37cited 37
  3. Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis
    Calero R, Morchon E, Johnsen JI, et al. · PloS one · 2014 · 被引 26cited 26
  4. Physicochemical characteristics of sunitinib malate and its process-related impurities
    Sidoryk K, Malińska M, Bańkowski K, et al. · Journal of pharmaceutical sciences · 2013 · 被引 10cited 10
  5. Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity
    Pan Z, Zhu L, Wang X, et al. · Autophagy · 2025 · 被引 4cited 4
  6. Spectrophotometric Methods for Determination of Sunitinib in Pharmaceutical Dosage Forms Based on Ion-pair Complex Formation
    Souri E, Amoon E, Shabani Ravari N, et al. · Iranian journal of pharmaceutical research : IJPR · 2020 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF SUNITINIB MALATE VIA SUNITINIB ACETATE AND THEIR POLYMORPHS
    JEGOROV ALEXANDR, GAVENDA ALES, VRASPIR PAVEL, CANAVESI AUGUSTO, et al. · 公开号 EP2373642EP2373642 · 2011
  2. PROCESS FOR THE PREPARATION OF MALIC ACID SALT OF SUNITINIB
    SANWAL SUDHIR SINGH, KUMAR SARIDI MADHAVA DILEEP, SATHYANARAYANA SWARGAM, THAPER RAJESH KUMAR, et al. · 公开号 WO2011114246WO2011114246 · 2011
  3. PROCESS FOR THE DIRECT PREPARATION OF MALIC ACID SALT OF SUNITINIB
    SANWAL SUDHIR SINGH, KUMAR SARIDI MADHAVA DILEEP, SATHYANARAYANA SWARGAM, THAPER RAJESH KUMAR, et al. · 公开号 WO2011107919WO2011107919 · 2011
  4. PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF
    BIGATTI ETTORE, CANAVESI AUGUSTO, MACDONALD PETER LINDSAY, SCARPITTA FRANCESCA · 公开号 US2010160646US2010160646 · 2010
  5. NOVEL POLYMORPHS OF SUNITINIB AND PROCESSES FOR THEIR PREPARATION
    GORE VINAYAK, CHOUDHARI BHARATI, HUBLIKAR MAHESH, BANSODE PRAKASH · 公开号 EP2318393EP2318393 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

舒尼替尼 杂质谱研究要点Sunitinib — impurity profiling notes

下面这些是拿到 舒尼替尼 的 63 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 63 impurity entries for Sunitinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances